QNCX
Quince Therapeutics
$17.85
−$0.01 (−0.03%)Jul 27, 2026
Key metrics
The numbers that frame QNCX today
- Market cap
- $14.55M
- P/E (TTM)
- -0.4
- EV / FCF
- 0.1
- ROIC
- -215.7%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $15.10
- 52wk High
- $909.98
Growth
Revenue and earnings trend for QNCX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about QNCX
Is Quince Therapeutics a good buy?
No. Quince Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of QNCX?
Quince Therapeutics's market capitalization is $14.55M.
What is the P/E ratio for QNCX stock?
Quince Therapeutics's current P/E ratio is -0.4.
What is the 52-week high for QNCX stock?
The 52-week high for Quince Therapeutics is $909.98. The current close of $17.85 is 98% below that high.
What is the 52-week low for QNCX stock?
The 52-week low for Quince Therapeutics is $15.10. The current close of $17.85 is 18.2% above that low.
Does QNCX stock pay dividends?
Quince Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for QNCX?
Quince Therapeutics's Debt / Equity ratio is 0.02.